Abstract
Experience of COVID 19 disease on 159 Ecuadorian chronic dialysis patients
Highlights
1.4.3.4: We recommend that clinical laboratories should (1B): K measure serum creatinine using a specific assay with calibration traceable to the international standard reference materials and minimal bias compared to isotope-dilution mass spectrometry (IDMS) reference methodology
3.1.11: We suggest that an angiotensin-receptor blocker (ARB) or angiotensin-converting enzyme inhibitor (ACE-I) be used in children with CHRONIC KIDNEY DISEASE (CKD) in whom treatment with blood pressure (BP)-lowering drugs is indicated, irrespective of the level of proteinuria. (2D)
We suggest that people with levels of intact parathyroid hormone (PTH) above the upper normal limit of the assay are first evaluated for hyperphosphatemia, hypocalcemia, and vitamin D deficiency. (2C)
Summary
This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE) www.publicationethics.org. 2012 CKD-EPI creatinine–cystatin C equation: 135  min(SCr/k, 1)a  max(SCr/k, 1)À0.601  min(SCysC/0.8, 1)À0.375  max(SCysC/ 0.8, 1)À0.711  0.995Age [  0.969 if female] [  1.08 if black], where SCr is serum creatinine (in mg/dl), SCysC is serum cystatin C (in mg/l), k is 0.7 for females and 0.9 for males, a is À0.248 for females and À0.207 for males, min(SCr/k, 1) indicates the minimum of SCr/k or 1, and max(SCr/k, 1) indicates the maximum of SCr/k or 1; min(SCysC/0.8, 1) indicates the minimum of SCysC/0.8 or 1 and max(SCysC/ 0.8, 1) indicates the maximum of SCysC/0.8 or 1. Prognosis of CKD by GFR and Albuminuria Categories: KDIGO 2012. GFR categories (ml/min/ 1.73 m2) Description and range
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have